The levels of colonic CCL25 had been shown to increase in both Crohn’s disease and ulcerative colitis, and pharmacological inhibitors of CCR9 prevented the development of ulcerative colitis in an experimental model [40]. The gene discussed is CCL25; the disease is ulcerative colitis.